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Fig 2. Completion Angiogram demonstrating successful exclusion of the
celiac aneurysm.
JOURNAL OF VASCULAR SURGERY
1162 Abstracts October 2013Endovascular Treatment of Celiac Artery Aneurysm with a Covered
Stent: Case Presentation and Review of the Literature
Micheal Ayad, Phil Batista, Anumeha Whisenhunt, Abai Babak, Salvatore
Dawn, Paul Dimuzio. Thomas Jefferson University Hospital, Philadelphia, Pa
Objectives: Celiac artery aneurysm is one of the rarest visceral arterial
aneurysms (<5% of cases). Management has traditionally involved open
repair (aneurysmorrhaphy or ligation) to prevent its rupture, which is
thought to occur approximately 15%-20% of cases. Endovascular options,
including embolization, percutaneous thrombin injection, and aortic and
celiac axis stent grafting have been described in the literature. Herein, we
present the successful repair of an asymptomatic celiac artery aneurysm
involving endovascular aneurysm repair of the celiac axis and coil emboliza-
tion of the splenic and left gastric arteries.
Methods: Preoperative planning involved ﬁne-cut computed tomo-
graphic angiography reformatted using TeraRecon software (TeraRecon,
Inc, Foster City, Calif) to accurately size the proposed endograft. Endovas-
cular repair was performed through a left brachial approach (6F system)
involving micro coil embolization (Cook Medical, Inc, Bloomington,
Ind) of the splenic and left gastric arteries, and placement of a Viabahn stent
graft (W. L. Gore and Associates, Inc, Flagstaff, Ariz) from the origin of the
celiac axis landing into the common hepatic artery. A review of the literature
was performed.
Results: Initial arteriogram (Fig 1) revealed the celiac aneurysm and
completion arteriography (Fig 2) demonstrated successful exclusion of the
celiac aneurysm without evidence of endoleak. The patient was discharged
postoperative day 1 in excellent condition, with normal liver function tests.
Follow-up at three months revealed complete exclusion of the aneurysm by
duplex imaging. A PUBMED literature search revealed the most common
endovascular approach was coil embolization of the aneurysm (six cases);
celiac aneurysm stent graft exclusion has been reported only in three cases;
celiac axis-hepatic artery stent graft placement, reported herein, has been
described only once previously.
Conclusions: Celiac axis aneurysm is a rare type of splanchnic aneu-
rysm with high rupture rate. Endovascular treatment requires careful preop-
erative planning and results in successful treatment via a minimally invasive
approach. When the aneurysm involves the distal celiac axis, EVAR
combined with selective embolization offers exclusion of the aneurysm
along with maintenance of in-line blood ﬂow to the liver.
Fig 1. Angiogram of celiac axis demonstrating 1.8 cm aneurysm. CA,
Celiac axis; CHA, common hepatic artery; LGA, left gastric artery; SA,
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Objectives: Renal artery aneurysms (RAAs) are rare but remain chal-
lenging lesions when treatment is required. Endovascular techniques may
offer less invasive options in some cases, but in many RAAs the distal or
hilar location of the aneurysm makes open surgical repair the only option.
Ex vivo RAA repair with aortorenal bypass and cold renal preservation
remains the deﬁnitive surgical treatment for these more complex distal
lesions. This study was a retrospective review of a single center experience
with ex vivo surgical treatment of 14 complex RAAs and their clinical
outcomes.
Methods: From January 1997 through January 2013, 14 consecutive
patients had RAAs repaired using ex vivo technique with cold renal perfu-
sion. Demographic data, comorbidities, pre- and postoperative imaging,
blood pressure, and renal function data, as well as operative details were
collected. Patency of repair and durability was followed with renal duplex
sonography.
Results: Fourteen RAAs were repaired in 10 women and four men
(average age 54 years). Preoperative hypertension was present in 12
(86%) requiring an average of three antihypertensive medications. Four
patients (29%) were active smokers. Renal insufﬁciency (creatinine >1.3
mg/dL) was present in 14%; the mean serum creatinine for the group
was 0.9 mg/dL. Six RAA (43%) were symptomatic. Aneurysm size averaged
2.88 cm (range, 1.3-5.3 cm). All reconstructions were performed with
autogenous saphenous vein aortorenal bypass. No patient required concom-
mitant aortic reconstruction. RAA repair and kidney salvage was successful
in 12 cases; two patients required nephrectomy due to unreconstructable
renal branch anatomy. There were no perioperative deaths, and average
length of stay was 8 days. Hypertension was clinically unchanged in all
patients. The two patients with pre-existing renal insufﬁciency had renal
function improved postoperatively. No patient required either temporary
or permanent dialysis. Follow-up with sonography was available in all
patients with a mean follow-up of 17 months (0.5-49 months), and showed
a patency of 100%.
Conclusions: Open ex vivo surgical repair with aortorenal bypass
was a successful and durable treatment for complex distal RAAs that
require repair. These procedures had low morbidity and mortality and an
excellent rate of preservation of renal function. However, blood pressure
control in these patients did not appear to change signiﬁcantly following
RRA repair.
